Breast cancer · Targeted therapy乳腺癌 · 靶向

Cost reference

Treatment path

Targeted therapy 靶向

Cost range

100000 – 195000 CNY

Caliber

Pre-reimbursement 医保报销前

Price basis

Per-item price 项目价

Data year

2025

Note

L1: drug price × standard dosage (trastuzumab single target → trastuzumab plus pertuzumab dual target; 18–19 cycles per year). L1 药价×标准用量换算（曲妥珠单抗单靶 → 曲帕双靶，1 年 18–19 周期）

Values written in Chinese are quoted as published by the source.